Literature DB >> 998323

Lithium treatment of a patient with periodic catatonia.

H Petursson.   

Abstract

This case report describes successful lithium treatment in a patient with long-standing periodic catatonia. Various medical treatments had been tried with meager results. Since 1955, a number of phenothiazines had been tried, also with little improvement. The institution of lithium treatment in 1964 caused a dramatic improvement in the patient's condition. For 9 years the patient remained totally asymptomatic. Lithium treatment was terminated in 1975 because of lithium intoxication with a diabetes insipidus-like syndrome. The patient then became psychotic again and has since experienced periodic phases similar to the previous illness. The diagnostic validity of the case is discussed, and some possible explanations of the favourable response to lithium are mentioned briefly.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 998323     DOI: 10.1111/j.1600-0447.1976.tb00118.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  5 in total

1.  Recurrent catatonia treated with lithium and carbamazepine: a series of 2 cases.

Authors:  Susanta K Padhy; Bn Subodh; Rahul Bharadwaj; K Arun Kumar; Suresh Kumar; Mk Srivastava
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Diagnosis and management of periodic catatonia.

Authors:  William M Hervey; Jonathan T Stewart; Glenn Catalano
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

3.  Efficacy of lithium in schizophrenia.

Authors:  S Dube; B B Sethi
Journal:  Indian J Psychiatry       Date:  1981-07       Impact factor: 1.759

Review 4.  Prevalence and description of psychotic features in bipolar mania.

Authors:  E Dunayevich; P E Keck
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

Review 5.  A clinical review of the treatment of catatonia.

Authors:  Pascal Sienaert; Dirk M Dhossche; Davy Vancampfort; Marc De Hert; Gábor Gazdag
Journal:  Front Psychiatry       Date:  2014-12-09       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.